← Eichor
Study identifier: NCT07655336 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

SPSIP Versus RISS Block in Volume-Preserving VATS

Condition: Postoperative Pain · Thoracic Surgery  ·  Sponsor: Ferit Yetik

PhaseNA
Planned participants84
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This prospective randomized controlled study aims to compare the effects of Serratus Posterior Superior Intercostal Plane (SPSIP) block and Rhomboid Intercostal and Subserratus (RISS) block on postoperative pain, respiratory function, and recovery quality in patients undergoing volume-preserving video-assisted thoracoscopic surgery (VATS). Eighty-four patients will be randomized in a 1:1 ratio to receive either SPSIP block or RISS block. The primary outcome is the incidence of somatic pain at the chest drain insertion site at postoperative 2 hours. Secondary outcomes include pain scores, opioid consumption, quality of recovery, diaphragmatic function, pulmonary function, rescue analgesic requirements, postoperative nausea and vomiting, and block-related complications.

This description comes directly from the study's public registry record.

Talk to the study team

Yusuf Alan  ·  +905396210977  ·  dryusufalan@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Bursa City HospitalBursa, Nilüfer, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07655336